¼¼°èÀÇ ÇÁ·ÎÅ×À̳ªÁ¦ K ½ÃÀå
Proteinase K
»óǰÄÚµå : 1773870
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 480 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,112,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,338,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÇÁ·ÎÅ×À̳ªÁ¦ K ¼¼°è ½ÃÀåÀº 2030³â±îÁö 67¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 46¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÇÁ·ÎÅ×À̳ªÁ¦ K ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 6.4%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 67¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ºÐ¸»Àº CAGR 5.3%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 42¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¾×ü ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 8.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 9.9%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÇÁ·ÎÅ×À̳ªÁ¦ K ½ÃÀåÀº 2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 9.9%¸¦ ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 3.3%¿Í 6.2%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÇÁ·ÎÅ×À̳ªÁ¦ K½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÇÁ·ÎÅ×À̳ªÁ¦ K°¡ ºÐÀÚ»ý¹°Çп¡¼­ ¼±ÅÃµÈ È¿¼ÒÀÎ ÀÌÀ¯´Â ¹«¾ùÀϱî? ±× ¿ªÇÒ°ú ¿ëµµ¿¡ ´ëÇØ ÀÚ¼¼È÷ ¾Ë¾Æº¸±â

ÇÁ·ÎÅ×À̳ªÁ¦ K´Â ±¤¹üÀ§ÇÑ ½ºÆåÆ®·³À» °¡Áø ¼¼¸° ÇÁ·ÎÅ×¾ÆÁ¦À̸ç, ºÐÀÚ»ý¹°ÇÐ, ¹ýÀÇÇÐ ¹× »ý¸í°øÇп¡¼­ ÇʼöÀûÀÎ µµ±¸°¡ µÇ°í ÀÖ½À´Ï´Ù. ¿ø·¡ Tritirachium album¿¡¼­ ºÐ¸®µÈ ÀÌ È¿¼Ò´Â ³×ÀÌÆ¼ºê ¹× º¯¼º ´Ü¹éÁúÀ» ¼ÒÈ­ÇÒ ¼ö ÀÖÀ¸¸ç, ¶Ù¾î³­ ´Ü¹éÁú ºÐÇØ Ȱ¼ºÀ» ³ªÅ¸³À´Ï´Ù. ¿¡½ºÅ׸£ °áÇÕ ¹× ÆéŸÀÌµå °áÇÕ¿¡ ´ëÇÑ Æ¯À̼ºÀÌ ³ô¾Æ DNA ¹× RNA »ùÇÃÀÇ ¹«°á¼ºÀ» ¼Õ»ó½ÃŰ´Â ´ºÅ¬·¹¾ÆÁ¦¿Í °°Àº ¿À¿° ¹°ÁúÀ» ºÐÇØÇÏ´Â µ¥ ¸Å¿ì È¿À²ÀûÀÔ´Ï´Ù. °¡Àå Áß¿äÇÑ ¿ëµµ Áß Çϳª´Â ÇÙ»ê Á¤Á¦À̸ç, PCR, ½ÃÄö½Ì, Ŭ·Î´× µîÀÇ ´Ù¿î½ºÆ®¸² °øÁ¤¿¡ ¹æÇذ¡ µÇ´Â ´Ü¹éÁúÀ» È®½ÇÇÏ°Ô Á¦°ÅÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÎÅ×À̳ªÁ¦ K´Â SDS, ¿ä¼Ò, EDTA¿Í °°Àº ¼¼Á¦¿¡ ÀÇÇÑ º¯¼º¿¡ ¸Å¿ì °­ÇÏ¿© À¯Àüü ¹× ´Ü¹éÁúüÇÐ ¿¬±¸¿¡¼­ Á¾Á¾ ¿ä±¸µÇ´Â °¡È¤ÇÑ Á¶°Ç¿¡ ÀûÇÕÇÕ´Ï´Ù. ³ÐÀº pH ¹üÀ§(7.5-12.0)¿Í °í¿Â(ÃÖ´ë 65¡É)¿¡¼­ ÃÖÀûÀÇ ±â´ÉÀ» ¹ßÈÖÇÒ ¼ö ÀÖ¾î ¿¬±¸ ¹× ÀÓ»ó ÀÀ¿ë ºÐ¾ß¿¡ ¼±È£µË´Ï´Ù. ¶ÇÇÑ, Á¶Á÷ ¼ÒÈ­ ÇÁ·ÎÅäÄÝ¿¡ »ç¿ëÇÏ¸é ´ÜÀÏ ¼¼Æ÷ ºÐ¸®¸¦ ¿ëÀÌÇÏ°Ô ÇÏ¿© ´ÜÀÏ ¼¼Æ÷ À¯ÀüüÇÐ ¹× Àü»çüÇÐÀÇ ¹ßÀü¿¡ Å©°Ô ±â¿©ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ È¿¼Ò´Â ¶ÇÇÑ »ê¾÷Àû ¿ëµµ, ƯÈ÷ ÀçÁ¶ÇÕ ´Ü¹éÁú »ý»ê¿¡¼­ ºÒÇÊ¿äÇÑ ¼÷ÁÖ ¼¼Æ÷ ´Ü¹éÁúÀ» Á¦°ÅÇÏ´Â µ¥ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®(NGS), Å©¸®½ºÆÛ(CRISPR) À¯ÀüÀÚ ÆíÁý ±â¼ú, ¾×ü »ý°Ë Áø´Ü¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÇÁ·ÎÅ×À̳ªÁ¦ KÀÇ ¼ö¿ä´Â ±ÞÁõÇÏ¿© ºÐÀÚ °úÇÐ ¹× ÀÀ¿ë °úÇп¡¼­ ±âÃÊ È¿¼Ò·Î¼­ÀÇ ÀÔÁö¸¦ È®°íÈ÷ Çϰí ÀÖ½À´Ï´Ù.

ÇÁ·ÎÅ×À̳ªÁ¦ K´Â ¹ýÀÇÇÐ ¹× ÀÓ»ó Áø´ÜÇп¡ ¾î¶² Çõ¸íÀ» ÀÏÀ¸Å°°í ÀÖÀ»±î?

ÇÁ·ÎÅ×À̳ªÁ¦ K°¡ ÀÏ»óÀûÀÎ ¿öÅ©Ç÷ο쿡 ÅëÇյǸ鼭 ¹ýÀÇÇÐ ¹× ÀÓ»ó Áø´Ü ºÐ¾ß´Â ÆÐ·¯´ÙÀÓÀÇ ÀüȯÀ» ¸ñ°ÝÇß½À´Ï´Ù. ÇÙ»êÀ» ¼Õ»ó½ÃŰÁö ¾Ê°í ´Ü¹éÁúÀ» ºÐÇØÇϴ Ź¿ùÇÑ È¿À²¼ºÀ¸·Î ÀÎÇØ ¹ýÀÇÇÐ DNA ÃßÃâÀÇ ±âº» ½Ã¾àÀÌ µÇ¾ú½À´Ï´Ù. ¹ýÁýÇà±â°üÀº Ç÷¾× ¾ó·è, ¸ð³¶, Ã˰¢ DNA¿Í °°Àº ¹Ì¼¼ÇÑ »ý¹°ÇÐÀû »ùÇÃÀ» ó¸®Çϱâ À§ÇØ ÀÌ È¿¼Ò¸¦ ¸¹ÀÌ »ç¿ëÇϰí ÀÖÀ¸¸ç, °íµµ·Î ºÐÇØµÈ »ùÇÿ¡¼­µµ À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµ¿¡ ¼º°øÇϰí ÀÖ½À´Ï´Ù. ÀÌ È¿¼ÒÀÇ °ß°í¼ºÀº ÀÓ»ó Áø´Ü, ƯÈ÷ º´¿øÃ¼ °ËÃ⠺м® ¹× À¯Àü¼º Áúȯ ½ºÅ©¸®´×, RNA ±â¹Ý Áø´Ü, ƯÈ÷ HIV, °£¿°, ÃÖ±Ù¿¡´Â SARS-CoV-2¿Í °°Àº Áúº´ÀÇ ¹ÙÀÌ·¯½º RNA ÃßÃâ ÇÁ·ÎÅäÄÝ¿¡ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. 19 ÆÒµ¥¹Í ±â°£ µ¿¾È ÇÁ·ÎÅ×À̳ªÁ¦ K´Â RT-PCR ±â¹Ý °Ë»ç¿¡ ÇʼöÀûÀÎ ½Ã¾àÀÌ µÇ¾úÀ¸¸ç, °¨¿°º´ °¨½Ã¿¡¼­ ±× Á߿伺À» ºÐ¸íÈ÷ Çß½À´Ï´Ù. Ç÷Àå »ùÇÿ¡¼­ ¼øÈ¯ Á¾¾ç DNA(ctDNA)ÀÇ ÃßÃâÀ» ¿ëÀÌÇÏ°Ô ÇÏ¿© ¾ÏÀÇ Á¶±â ¹ß°ß ¹× °³º°È­µÈ Ä¡·á Àü·«À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ, ¹ÚÅ׸®¾Æ¿Í ¹ÙÀÌ·¯½ºÀÇ ¸·À» ¿ëÇØÇÔÀ¸·Î½á ¸ÞŸÀ¯Àüü ¿¬±¸¸¦ °­È­ÇÏ¿© ¿¬±¸ÀÚµéÀÌ ÀÎü ³» ¹Ì»ý¹° »ýŰ踦 ÇØµ¶ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. Àΰ£ °Ç°­»Ó¸¸ ¾Æ´Ï¶ó º¹ÀâÇÑ »ý¹°ÇÐÀû ¸ÅÆ®¸¯½º¿¡¼­ °íǰÁú DNA¿Í RNA¸¦ ÃßÃâÇÏ´Â ÇÁ·ÎÅ×À̳ªÁ¦ KÀÇ ´É·ÂÀº µ¿¹° Áø´Ü¿¡µµ µµ¿òÀÌ µÇ¾î Áúº´ ¸ð´ÏÅ͸µ°ú °¡ÃàÀÇ °Ç°­ °ü¸®¿¡µµ µµ¿òÀÌ µÇ°í ÀÖ½À´Ï´Ù. Áø´Ü ±â¼úÀÇ Áö¼ÓÀûÀÎ ¹ßÀü°ú ºñħ½ÀÀû °Ë»ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÇÁ·ÎÅ×À̳ªÁ¦KÀÇ ¿ªÇÒÀº Á¤¹ÐÀÇ·á ¹× º´¿øÃ¼ °¨½Ã ½Ã½ºÅÛ¿¡¼­ ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÇÁ·ÎÅ×¾ÆÁ¦ KÀÇ ±ÞÁõÇÏ´Â ¼ö¿ä¸¦ ¹ÙÀÌ¿ÀÁ¦¾à°ú »ê¾÷°è°¡ µû¶ó°¥ ¼ö ÀÖÀ»±î?

¹ÙÀÌ¿ÀÀǾàǰ ¹× »ê¾÷ ºÐ¾ßÀÇ Æø¹ßÀûÀÎ ¼ºÀåÀ¸·Î °íǰÁú ÇÁ·ÎÅ×À̳ªÁ¦ K¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À¯ÀüÀÚ Ä¡·á ¹× ¹é½Å °³¹ß¿¡ ÇʼöÀûÀÎ ÇÃ¶ó½º¹Ìµå ¹× ¹ÙÀÌ·¯½º º¤ÅÍÀÇ Á¤Á¦¸¦ µ½´Â ÀçÁ¶ÇÕ DNA ±â¼ú·ÎÀÇ Àû¿ëÀº °¡Àå Áß¿äÇÑ ¿øµ¿·Â Áß ÇϳªÀ̸ç, CAR-T ¼¼Æ÷ Ä¡·á ¹× Áٱ⼼Æ÷ ¿¬±¸ µî ±Þ¼ºÀåÇϰí ÀÖ´Â ¼¼Æ÷ ¹× À¯ÀüÀÚ Ä¡·á ºÐ¾ß¿¡¼­´Â À¯ÀüÀÚ Á¶ÀÛµÈ ¼¼Æ÷·ÎºÎÅÍ DNA ¹× RNA¸¦ ºÐ¸®ÇÏ´Â µ¥¿¡ ÇÁ·ÎÅ×À̳ªÁ¦ K°¡ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Á¦¾à »ê¾÷¿¡¼­ ÀÌ È¿¼Ò´Â Ä¡·á¿ë ´Ü¹éÁú »ý»ê¿¡ ³Î¸® »ç¿ëµÇ¾î ¾àÈ¿¸¦ ÀúÇØÇÒ ¼ö ÀÖ´Â ¼÷ÁÖ ¼¼Æ÷ÀÇ ´Ü¹éÁú°ú ³»µ¶¼Ò¸¦ È®½ÇÇÏ°Ô Á¦°ÅÇÕ´Ï´Ù. È¿¼Ò¿¡ ´ëÇÑ ¼ö¿ä´Â »ý¹°ÇÐÀû Ä¡·á, ¼¼Á¦ Á¦Á¶ ¹× ½Äǰ °¡°ø°ú °°Àº »ê¾÷ °øÁ¤¿¡¼­ ÇÁ·ÎÅ×À̳ªÁ¦ KÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. ¼¼Á¦ »ê¾÷¿¡¼­´Â °¡È¤ÇÑ Á¶°Ç¿¡¼­ ¾ÈÁ¤¼ºÀÌ ¶Ù¾î³ª ƯÈ÷ È¿¼Ò ¼¼Å¹ ¼¼Á¦ÀÇ ¾ó·è Á¦°ÅÁ¦ ¹èÇÕ¿¡ ÀÌ»óÀûÀÎ ¼ººÐÀÔ´Ï´Ù. ÇÑÆí, ¹ÙÀÌ¿À ¸®¸ÞµðÄÉÀ̼ǿ¡¼­´Â ´Ü¹éÁú ºÐÇØ Ư¼ºÀÌ À¯±â ¿À¿° ¹°ÁúÀÇ ºÐÇØ¸¦ µµ¿Í ģȯ°æÀûÀÎ Æó±â¹° °ü¸® ¼Ö·ç¼Ç¿¡ ±â¿©ÇÕ´Ï´Ù. ¶ÇÇÑ, ÇÁ·ÎÅ×À̳ªÁ¦ K´Â ÇコÄÉ¾î ¹× »ê¾÷ ȯ°æ¿¡¼­ÀÇ ¹Ì»ý¹° ¿À¿° ¹æÁö¸¦ ÀǹÌÇÏ´Â ¹ÙÀÌ¿ÀÇʸ§ ÆÄ±«¿¡ ´ëÇÑ ¿ªÇÒ¿¡ ´ëÇØ¼­µµ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ´Ù¾çÇÑ ¿ëµµ¸¦ °í·ÁÇÏ¿© Àü ¼¼°è Á¦Á¶¾÷üµéÀº »ý»ê´É·ÂÀ» °­È­Çϰí ÀÖÀ¸¸ç, Áö¼Ó°¡´É¼º°ú °ø±Þ¸Á ¾ÈÁ¤¼ºÀ» º¸ÀåÇϱâ À§ÇØ ÀçÁ¶ÇÕ ÇÁ·ÎÅ׾Ƴ×ÀÌÁî K·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. È¿¼Ò °øÇп¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¾ÈÁ¤¼º°ú ƯÀ̼ºÀ» °­È­ÇÑ °³·®Çü ÇÁ·ÎÅ׾Ƴ×ÀÌÁî Kµµ ½ÃÀå¿¡ ÁøÀÔÇϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ »ê¾÷¿¡¼­ÀÇ °¡´É¼ºÀ» ´õ¿í ³ÐÈ÷°í ÀÖ½À´Ï´Ù.

ÇÁ·ÎÅ×À̳ªÁ¦ K ¼¼°è ½ÃÀå ¼ºÀå ¿øµ¿·ÂÀº? ÁÖ¿ä ÃËÁø¿äÀΰú »õ·Î¿î Æ®·»µå

ÇÁ·ÎÅ×À̳ªÁ¦ K ¼¼°è ½ÃÀå ¼ºÀåÀº ÁÖ·Î ºÐÀÚ»ý¹°ÇÐ, ¹ýÀÇÇÐ, ÀÓ»ó Áø´Ü, »ê¾÷ »ý¸í°øÇÐ ºÐ¾ßÀÇ ¼ö¿ä Áõ°¡ µî ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®±â(NGS)¿Í CRISPR ±â¹Ý À¯ÀüÀÚ ÆíÁý ±â¼úÀÇ Ã¤ÅÃÀÌ ±ÞÁõÇϰí ÀÖÀ¸¸ç, µÑ ´Ù ÇÁ·ÎÅ×À̳ªÁ¦ K¿¡ ÀÇÇØ ÃËÁøµÇ´Â °í¼øµµ DNA ¹× RNA ÃßÃâÀ» ÇÊ¿ä·Î ÇÕ´Ï´Ù. À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¸ÂÃãÇü ÀÇ·á·ÎÀÇ ÀüȯÀº °íǰÁú ÇÙ»ê ºÐ¸®ÀÇ Çʿ伺À» ´õ¿í Áõ°¡½ÃÄÑ ½ÃÀå ¼ö¿ä¸¦ °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¹ýÀÇÇÐ ÀÀ¿ë ºÐ¾ß¿¡¼­´Â ÅÍÄ¡ DNA ºÐ¼®°ú ¹Ì´Ï STR ±â¼úÀÇ ¹ßÀüÀ¸·Î ¹ýÁýÇà±â°üÀÌ ÇÁ·ÎÅ×¾ÆÁ¦ K ±â¹Ý ÃßÃâ ¹æ¹ýÀ» äÅÃÇÏ¿© ¿­È­µÈ ½Ã·áÀÇ ´õ ³ªÀº ÇÁ·ÎÆÄÀϸµÀ» º¸ÀåÇÕ´Ï´Ù. ÇÑÆí, ÀÓ»ó Áø´Ü¿¡¼­´Â ½Å¼ÓÇϰí È¿À²ÀûÀÎ ¹ÙÀÌ·¯½º RNA ÃßÃâ¿¡ ´ëÇÑ ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖÀ¸¸ç, ƯÈ÷ °¨¿°¼º Áúȯ, ¾Ï °ËÁø, »êÀü Áø´ÜÀ» À§ÇÑ ºÐÀÚ °Ë»ç¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿ÀÀǾàǰ, ƯÈ÷ ÀçÁ¶ÇÕ ´Ü¹éÁú Ä¡·áÁ¦, ¹é½Å °³¹ß, À¯ÀüÀÚ Ä¡·áÁ¦ Á¦Á¶ÀÇ ºÎ»óÀ¸·Î ¹ÙÀÌ¿ÀÀǾàǰ¿¡¼­ È¿¼ÒÀÇ ¿ªÇÒµµ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼¼Á¦, ½Äǰ °¡°ø, ¼¶À¯ »ê¾÷ µî È¿¼Ò¸¦ ±â¹ÝÀ¸·Î ÇÑ »ê¾÷Àû ¿ëµµÀÇ ±Þ¼ÓÇÑ È®ÀåÀº ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. È¿¼Ò °øÇÐÀÇ ±â¼ú ¹ßÀüÀº ÇÁ·ÎÅ׾Ƴ×ÀÌÁî KÀÇ ¾ÈÁ¤¼º, ƯÀ̼º ¹× ºñ¿ë È¿À²¼ºÀ» ´õ¿í Çâ»ó½ÃÄÑ ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡ ´õ¿í ¸Å·ÂÀûÀÎ ¼±ÅÃÀÌ µÇ°í ÀÖ½À´Ï´Ù. ½ÃÀåÀ» Çü¼ºÇÏ´Â ¶Ç ´Ù¸¥ Áß¿äÇÑ Æ®·»µå´Â À±¸®Àû, ±ÔÁ¦Àû ±âÁØ¿¡ ºÎÇÕÇÏ´Â Áö¼Ó°¡´ÉÇÏ°í µ¿¹°¼º È¿¼Ò °ø±Þ¿øÀÌ ÇÊ¿äÇÔ¿¡ µû¶ó ÀçÁ¶ÇÕ ÇÁ·ÎÅ׾Ƴ×ÀÌÁî K »ý»êÀ¸·Î ÀüȯÇϰí ÀÖ´Â °ÍÀÔ´Ï´Ù. »ý¸í°øÇÐ ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡, ¹ýÀÇÇÐ ¹× ÀÓ»ó Áø´Ü¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, »ê¾÷ °øÁ¤¿¡¼­ ÇÕ¼º»ý¹°ÇÐÀÇ Ä§Åõ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÇÁ·ÎÅ׾Ƴ×ÀÌÁî K ½ÃÀåÀº ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÏ°Ô È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¹®

ÇüÅÂ(ºÐ¸», ¾×ü), Ä¡·á ºÐ¾ß(°¨¿°Áõ, ´ç´¢º´, Á¾¾ç, ½ÉÀ庴, ½ÅÀ庴, ÀÚ°¡¸é¿ªÁúȯ, ½Å°æ, ±âŸ), ¿ëµµ(À¯Àüü DNA¿Í RNA ºÐ¸® Á¤Á¦, ISH(In Situ Hybridization), ¹ÌÅäÄܵ帮¾Æ ºÐ¸®), ÃÖÁ¾ ¿ëµµ(°è¾à ¿¬±¸±â°ü, Çмú±â°ü, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, Áø´Ü ¿¬±¸¼Ò)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹üÀ» µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Proteinase K Market to Reach US$6.7 Billion by 2030

The global market for Proteinase K estimated at US$4.6 Billion in the year 2024, is expected to reach US$6.7 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2024-2030. Powder, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.2 Billion by the end of the analysis period. Growth in the Liquid segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 9.9% CAGR

The Proteinase K market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 9.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Proteinase K Market - Key Trends & Drivers Summarized

Why Is Proteinase K the Enzyme of Choice in Molecular Biology? A Deep Dive into Its Role & Applications

Proteinase K, a broad-spectrum serine protease, has emerged as an indispensable tool in molecular biology, forensic science, and biotechnology. Originally isolated from Tritirachium album, this enzyme exhibits exceptional proteolytic activity, capable of digesting native and denatured proteins. Its high specificity towards ester and peptide bonds makes it highly efficient in breaking down contaminants like nucleases, which can compromise the integrity of DNA and RNA samples. One of its most significant applications is in nucleic acid purification, where it ensures the removal of proteins that could hinder downstream applications such as PCR, sequencing, and cloning. Additionally, Proteinase K is highly resistant to denaturation by detergents like SDS, urea, and EDTA, making it suitable for harsh conditions often required in genomic and proteomic studies. Its ability to function optimally across a broad pH range (7.5-12.0) and at high temperatures (up to 65°C) makes it a preferred choice for research and clinical applications. Moreover, its use in tissue digestion protocols facilitates single-cell isolation, contributing significantly to advancements in single-cell genomics and transcriptomics. The enzyme has also found its way into industrial applications, particularly in recombinant protein production, where it helps eliminate unwanted host cell proteins. With the increasing reliance on next-generation sequencing (NGS), CRISPR gene-editing technologies, and liquid biopsy diagnostics, the demand for Proteinase K has surged, solidifying its position as a cornerstone enzyme in molecular and applied sciences.

How Is Proteinase K Revolutionizing Forensic & Clinical Diagnostics?

The forensic and clinical diagnostic sectors have witnessed a paradigm shift with the integration of Proteinase K into routine workflows. Its unparalleled efficiency in degrading proteins without compromising nucleic acids has made it a fundamental reagent in forensic DNA extraction. Law enforcement agencies rely heavily on this enzyme to process minute biological samples-such as blood stains, hair follicles, and touch DNA-ensuring successful genetic profiling even from highly degraded samples. The enzyme’s robustness also plays a critical role in clinical diagnostics, particularly in pathogen detection assays and hereditary disease screening. It is extensively used in RNA-based diagnostics, especially in viral RNA extraction protocols for diseases such as HIV, hepatitis, and more recently, SARS-CoV-2. During the COVID-19 pandemic, Proteinase K became an essential reagent in RT-PCR-based testing, underscoring its importance in infectious disease surveillance. Another breakthrough has been its application in liquid biopsies, where it facilitates the extraction of circulating tumor DNA (ctDNA) from plasma samples, enabling early cancer detection and personalized treatment strategies. In addition, its utility in lysing bacterial and viral membranes has enhanced metagenomic studies, allowing researchers to decode the microbial ecosystem within the human body. Beyond human health, veterinary diagnostics have also benefitted from Proteinase K’s ability to extract high-quality DNA and RNA from complex biological matrices, aiding in disease monitoring and livestock health management. With continuous advancements in diagnostic technologies and the increasing focus on non-invasive testing, the role of Proteinase K is expected to expand further in precision medicine and pathogen surveillance systems.

Can the Biopharmaceutical & Industrial Sectors Keep Up With the Soaring Demand for Proteinase K?

The explosive growth in the biopharmaceutical and industrial sectors has intensified the need for high-quality Proteinase K. One of the most significant drivers is its application in recombinant DNA technology, where it aids in plasmid and viral vector purification, essential for gene therapy and vaccine development. The booming field of cell and gene therapy, including CAR-T cell treatments and stem cell research, heavily relies on Proteinase K for DNA and RNA isolation from genetically engineered cells. In the pharmaceutical industry, the enzyme is extensively used in the production of therapeutic proteins, ensuring the removal of host cell proteins and endotoxins that could interfere with drug efficacy. The enzyme’s demand has also been propelled by the increasing adoption of Proteinase K in industrial processes such as bioremediation, detergent formulation, and food processing. In the detergent industry, its stability under extreme conditions makes it an ideal component for stain removal formulations, especially in enzymatic laundry detergents. Meanwhile, in bioremediation, its protein-degrading properties assist in the breakdown of organic pollutants, contributing to eco-friendly waste management solutions. Additionally, Proteinase K is being explored for its role in biofilm disruption, which has implications in preventing microbial contamination in healthcare and industrial settings. Given these diverse applications, global manufacturers are ramping up production capacities, with an increasing shift toward recombinant Proteinase K to ensure sustainability and supply chain stability. With growing investments in enzyme engineering, modified Proteinase K variants with enhanced stability and specificity are also entering the market, further expanding its potential in diverse industries.

What Is Fueling the Growth of the Global Proteinase K Market? Key Drivers & Emerging Trends

The growth in the global Proteinase K market is driven by several factors, primarily the rising demand from molecular biology, forensic science, clinical diagnostics, and industrial biotechnology. One of the major drivers is the surging adoption of next-generation sequencing (NGS) and CRISPR-based gene-editing technologies, both of which require high-purity DNA and RNA extraction facilitated by Proteinase K. The growing prevalence of genetic disorders and the shift toward personalized medicine have further heightened the need for high-quality nucleic acid isolation, accelerating market demand. In forensic applications, advancements in touch DNA analysis and mini-STR techniques are pushing law enforcement agencies to adopt Proteinase K-based extraction methods, ensuring better profiling of degraded samples. Meanwhile, in clinical diagnostics, the demand for rapid and efficient viral RNA extraction has surged, especially with the increasing reliance on molecular testing for infectious diseases, cancer screening, and prenatal diagnostics. The enzyme’s role in biopharmaceuticals is also expanding, particularly with the rise of recombinant protein therapeutics, vaccine development, and gene therapy manufacturing. Additionally, the rapid expansion of enzyme-based industrial applications-including its use in the detergent, food processing, and textile industries-is bolstering market growth. Technological advancements in enzyme engineering are further enhancing Proteinase K’s stability, specificity, and cost-effectiveness, making it an even more attractive option for various applications. Another key trend shaping the market is the shift toward recombinant Proteinase K production, driven by the need for sustainable, animal-free enzyme sources that align with ethical and regulatory standards. With increased funding for biotech research, growing awareness of forensic and clinical diagnostics, and the rising penetration of synthetic biology in industrial processes, the Proteinase K market is set for robust expansion in the coming years.

SCOPE OF STUDY:

The report analyzes the Proteinase K market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Form (Powder, Liquid); Therapeutic Area (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Neurology, Others); Application (Isolation & Purification of Genomic DNA & RNA, In Situ Hybridization, Mitochondria isolation); End-Use (Contract Research Organization, Academic Institutes, Biotechnology Companies, Diagnostic Laboratories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â